The imaging of specific molecular targets that are associated with cancer should allow
earlier diagnosis and better management of oncology patients. Positron emission …

Breast cancer is a complex disease which is found as the second cause of cancer‐
associated death among women. Accumulating of evidence indicated that various factors …

Multiple biomedical imaging techniques are used in all phases of cancer management.
Imaging forms an essential part of cancer clinical protocols and is able to furnish …

Purpose The aim of this study was to determine the impact of the main clinicopathological
and biological prognostic factors of breast cancer on 18 F-fluorodeoxyglucose (FDG) uptake …

Breast cancer is characterized by elevated glucose consumption resulting in increased
uptake of 18F-FDG. However, tracer uptake varies considerably among tumors imaged with …

Positron emission tomography (PET) is now primarily used in oncological indication owing
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …

Positron emission tomography (PET) is a radiotracer imaging method that yields quantitative
images of regional in vivo biology and biochemistry. PET, now used in conjunction with …

Estrogen receptor (ER) status by immunohistochemistry (IHC) of cancer tissue is currently
used to direct endocrine therapy in breast cancer. Positron emission tomography (PET) with …

Purpose In breast cancer,[18F] fluoroestradiol (FES) positron emission tomography (PET)
correlates with estrogen receptors (ER) expression and predicts response to tamoxifen. We …

The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …